Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Organon And Henlius Are Latest To Receive Denosumab Nod In US
Partners Get FDA Approval For Biosimilar Rivals To Prolia And Xgeva
Sep 03 2025
•
By
Dave Wallace
The FDA has approved Henlius and Organon’s denosumab biosimilars
(Shutterstock)
More from Biosimilars
More from Products